← Back to Search

Sleep Extension for Vascular Health (SAVHS Trial)

N/A

Recruiting

Research Sponsored by Auburn University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Free from metabolic disease

Age between 18 and 25 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change score from habitual sleep to day 15 (after 14 days of sleep extension)

Awards & highlights

SAVHS Trial Summary

This trial found that not getting enough sleep puts adults, especially those 18-25, at increased risk for cardiovascular disease and death. Poor sleep affects the heart and blood pressure, so getting 7-9 hours is important for health.

Who is the study for?

This trial is for young adults aged 18-25 who usually sleep less than 7 hours a night and don't have lung, metabolic, liver, or heart diseases. They should not have severe food allergies, eating disorders, high blood pressure (over 140/80 mmHg), a BMI over 35 kg/m2, be on blood thinners or have a history of sleeping disorders.Check my eligibility

What is being tested?

The study looks at whether increasing sleep to the recommended 7-9 hours can improve heart and metabolic health in young adults. It aims to understand how better sleep might lower the risk of cardiovascular disease by examining changes in participants' vascular function.See study design

What are the potential side effects?

Since this intervention involves non-medical methods like adjusting sleep patterns rather than taking drugs or undergoing surgery, side effects are minimal but may include temporary changes in mood or alertness.

SAVHS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I do not have any metabolic diseases.

Select...

I am between 18 and 25 years old.

Select...

I do not have any lung diseases.

Select...

My liver is healthy.

Select...

I do not have any heart diseases.

SAVHS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change score from habitual sleep to day 15 (after 14 days of sleep extension)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change score from habitual sleep to day 15 (after 14 days of sleep extension)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change score from habitual sleep to day 15 (after 14 days of sleep extension) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Blood pressure reactivity

Circulating Ghrelin

Circulating Leptin

+11 more

Secondary outcome measures

Appetite Assessment

Blood Cholesterol

Blood Glucose

+8 more

SAVHS Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Sleep extensionExperimental Treatment1 Intervention

Participants will extend their time in bed by one hour for 2 weeks while being monitored.

Group II: Habitual SleepActive Control1 Intervention

Participants will follow their normal sleep schedule for 2 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Sleep Extension

2017

N/A

~400

0 / 5Eligibility criteria met

Find a Location

Who is running the clinical trial?

Auburn UniversityLead Sponsor

72 Previous Clinical Trials

14,343 Total Patients Enrolled

Media Library

Sleep extension Clinical Trial Eligibility Overview. Trial Name: NCT05918744 — N/A

Metabolic Diseases Research Study Groups: Habitual Sleep, Sleep extension

Metabolic Diseases Clinical Trial 2023: Sleep extension Highlights & Side Effects. Trial Name: NCT05918744 — N/A

Sleep extension 2023 Treatment Timeline for Medical Study. Trial Name: NCT05918744 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment have any open slots for participants?

"The clinicaltrials.gov website indicates that this particular study, which was first posted on July 30th 2023 and last updated June 15th 2023 is no longer actively searching for patients. Nevertheless, 385 other trials are still recruiting right now."

Answered by AI

Is the study open to individuals who are above forty years old?

"As stated in the prerequisites for this clinical trial, only individuals between 18 and 25 years old can be accepted."

Answered by AI

Might I be a suitable participant in this research project?

"The requisite criteria to join this medical trial are cardiovascular disease and being aged between 18 and 25. This research project is set to recruit a total of 60 individuals."

Answered by AI

What is the fundamental aim of this clinical research?

"This trial will be evaluated over a 14-day period to observe the effect of sleep extension on Passive Leg Movement. Secondary objectives include measuring mental health, specifically social anxiety (utilizing the Liebowitz Social Anxiety Scale), appetite assessment via visual analog scale and ad libitum breakfast intake, as well as hematocrit content in blood samples."

Answered by AI

Recent research and studies

Sleep HealthJournal

National Sleep Foundation’s Sleep Time Duration Recommendations: Methodology and Results Summary

Hirshkowitz, Max, Kaitlyn Whiton, Steven M. Albert, Cathy Alessi, Oliviero Bruni, Lydia DonCarlos, Nancy Hazen, et al.. 2015. “National Sleep Foundation’s Sleep Time Duration Recommendations: Methodology and Results Summary”. Sleep Health. Elsevier BV. doi:10.1016/j.sleh.2014.12.010.

clinicaltrials.govStudy

Sleep and Vascular Health Study

Austin Robinson 2023. "Sleep and Vascular Health Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05918744.